Newly Established Medical Devices Company Investment Opportunity in London, United Kingdom

- We have a focused objective of bringing our technology for respiratory and prostate cancer to the market as quickly as possible and aim to have the respiratory device in the market within 12 months and the prostate cancer device in the market within 24 months, whilst developing further tests at the same time for more population illnesses.

- We are able currently to test for Covid with one of our devices.

- This device is in the development stages.

- Our company will generate revenue by selling our devices.

- The devices will be manufactured by third parties but will be sold under our brand name.

The technology will be used as a portable point-of-care platform by hospitals, laboratories, diagnostic centers, care homes, and beyond. We are able currently to test for Covid and are now designing and developing a new test for other respiratory diseases and prostate cancer all giving instant results. With the team and partners we have in place, we are in a strong position to market the technology on a global scale both academically and commercially.

Our technology provides instant results and has been proven with Covid. As a point-of-care test, it can go where it is needed, any place, anytime. Designing and developing our devices initially for prostate cancer and respiratory diseases will have an enormous impact on human lives and significant commercial value.

Physical assets include raw materials, consumables, and devices for testing and clinical trials.

Intangible assets include IP and technology.

Our business has offices in London, Birkenhead, and Ireland. All the offices are rented. The London office is our headquarter is located in the north of the city.

At present, a new business entity has been set up for the new technology we are developing and is in partnership with the Liverpool School of Tropical Medicine and the University of Liverpool. The business is funded by owners' capital. The company has one owner with a 100% stake in the company. The business does not have any outstanding liabilities.